Jennifer J Rhodes's Net Worth
$2.79 Million
Who is Jennifer J Rhodes?
Jennifer J Rhodes has an estimated net worth of $2.79 Million. This is based on reported shares across multiple companies, which include Angion Biomedica Corp., Adamas Pharmaceuticals Inc, and MEDIVATION, INC..
SEC CIK
Jennifer J Rhodes's CIK is 0001568249
Past Insider Trading and Trends
2015 was Jennifer J Rhodes's most active year for acquiring shares with 4 total transactions. Jennifer J Rhodes's most active month to acquire stocks was the month of January. 2021 was Jennifer J Rhodes's most active year for disposing of shares, totalling 12 transactions. Jennifer J Rhodes's most active month to dispose stocks was the month of December. 2015 saw Jennifer J Rhodes paying a total of $189,920.00 for 26,500 shares, this is the most they've acquired in one year. In 2014 Jennifer J Rhodes cashed out on 42,910 shares for a total of $1,835,499.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Angion Biomedica Corp. (ELTX) Snapshot price: $3.97
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| -1.46% | -451.00 |
$2.42 | -$1,090.11 | 30.4K |
Scheduled
|
Dec 14
| ||
Form 4
| -1.38% | -433.00 |
$4.40 | -$1,905.20 | 30.85K |
Scheduled
|
Nov 15
| ||
Form 4
| -1.36% | -430.00 |
$8.65 | -$3,719.50 | 31.28K |
Scheduled
|
Oct 14
| ||
Form 4
| -1.34% | -430.00 |
$10.64 | -$4,575.20 | 31.71K |
Scheduled
|
Sep 14
| ||
Form 4
| -1.37% | -445.00 |
$10.68 | -$4,752.60 | 32.14K |
Scheduled
|
Aug 16
| ||
Form 4
| -1.31% | -432.00 |
$10.94 | -$4,726.08 | 32.59K |
Scheduled
|
Jul 21
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -1.31% | -431.00 |
$11.01 | -$4,745.31 | 32.59K |
Scheduled
|
Jul 14
| ||
Form 4
| -1.28% | -427.00 |
$13.27 | -$5,666.29 | 33.02K |
Scheduled
|
Jun 14
| ||
Form 4
| -1.30% | -440.00 |
$13.92 | -$6,124.80 | 33.45K |
Scheduled
|
May 14
| ||
Form 4
| -1.16% | -399.00 |
$15.01 | -$5,988.99 | 33.89K |
Scheduled
|
Apr 15
| ||
Form 4
| -1.43% | -499.00 |
$20.45 | -$10,204.55 | 34.29K |
Mar 13
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -1.30% | -457.00 |
$19.54 | -$8,929.78 | 34.78K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adamas Pharmaceuticals Inc No price found
CBO, GC & Compliance Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.47% | -940.00 |
$5.35 | -$5,029.00 | 63.11K |
Jun 20
| |||
Form 4
| +94.90% | 30K |
—
|
—
| 61.61K |
Apr 8
| |||
Form 4
| -5.36% | -1.79K |
$7.99 | -$14,318.08 | 31.61K |
Mar 20
| |||
Form 4
| -1.26% | -425.00 |
$7.52 | -$3,196.00 | 33.4K |
Dec 20
| |||
Form 4
| -2.88% | -1.00K |
$25.48 | -$25,530.96 | 33.79K |
Jun 21
| |||
Form 4
| -2.80% | -982.00 |
$25.89 | -$25,423.98 | 34.13K |
Mar 21
| |||
Form 4
| +21.66% | 6.25K |
—
|
—
| 35.11K |
Mar 6
| |||
Form 4
| -1.50% | -440.00 |
$32.30 | -$14,212.00 | 28.86K |
Dec 21
| |||
Form 4
| -3.53% | -1.04K |
$17.53 | -$18,253.73 | 28.45K |
Jun 21
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +70.59% | 11.25K |
—
|
—
| 27.19K |
Jan 18
| |||
Form 4
| +41.66% | 4.69K |
—
|
—
| 15.94K |
Nov 7
| |||
Form 4
|
∞
| 11.25K |
—
|
—
| 11.25K |
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MEDIVATION, INC. No price found
GC & Corporate Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.14% | -1.39K |
$130.92 | -$181,978.94 | 11.09K |
Mar 16
| |||
Form 4
|
—
|
0
|
$84.74 | -$149,040.00 | 12.48K |
Scheduled
|
Mar 2
| ||
Form 4
| -8.73% | -1.09K |
$83.39 | -$273,542.00 | 11.39K |
Scheduled
|
Feb 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +38.98% | 3.5K |
—
|
—
| 12.48K |
Feb 9
| |||
Form 4
| -6.36% | -610.00 |
$100.85 | -$61,518.68 | 8.98K |
Scheduled
|
Feb 4
| ||
Form 4
| -8.67% | -910.00 |
$113.00 | -$102,830.00 | 9.59K |
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +75.00% | 4.5K |
—
|
—
| 10.5K |
Feb 4
| |||
Form 4
| -82.35% | -28.00K |
$61.88 | -$1,732,669.00 | 6K |
Scheduled
|
Jan 21
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACADIA PHARMACEUTICALS INC (ACAD) No price found
EVP, CHIEF LEGAL OFFICER, SEC
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||